Watch HCAT. Know when insiders buy.
One email the day a filing lands. Free.
HCAT
Health Catalyst, Inc.
1.69
−0.10 −5.59%
USD · close Oct 30
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
77
PASS · insiders 60, shorts 93
Insiders, 90 days
+$105K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $127.2MP/E —DIV YIELD —FCF YIELD 21.25%REV TTM $292.2M −7.5%NET INCOME −$264.8MNET DEBT $92.9M52W 1.00 – 3.14SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose HCAT in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Palogic Value Management, LP and 3 related7.1%
“Item 4 is hereby amended and supplemented as follows: "On September 4, 2026, Palogic Value Management sent a letter (the "September 2026 Letter") to the Board of Directors of the Issuer following the Issuer's VitalWare sale. In the September 2026 Letter, Palogic Value Management applauded the sale a…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.